Andreas Meudt

Title: Andreas Meudt: Innovator in Pharmaceutical Chemistry

Introduction

Andreas Meudt is a notable inventor based in Sulzbach, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work has implications for various therapeutic applications, showcasing his expertise and innovative spirit.

Latest Patents

Andreas Meudt holds a patent for "Protected forms of N-(3-methoxy-5-methylpiperazin-2-yl)-2-(4-[1,3,4,-oxadiazol-2-yl]phenyl)-pyridine-3-sulphonamide." This invention relates to compounds where P is a nitrogen-protecting group, along with processes for preparing these compounds. His patent reflects his commitment to advancing pharmaceutical science and improving drug formulations.

Career Highlights

Andreas is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to the development of innovative therapies. His work is characterized by a focus on creating effective and safe pharmaceutical products.

Collaborations

Andreas has worked alongside talented colleagues, including Margaret Anne Butlin and Roger John Butlin. These collaborations have enriched his research and contributed to the success of various projects within the pharmaceutical industry.

Conclusion

Andreas Meudt is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patent and contributions at AstraZeneca AB highlight his dedication to advancing healthcare through scientific research.